Hemodynamic Optimization By Non-Invasive Determination Of Cardiac Output In Critically Ill Patients
HEMODYNAMIC OPTIMIZATION BY NON-INVASIVE DETERMINATION OF CARDIAC OUTPUT IN CRITICALLY ILL PATIENTS: A RANDOMIZED, CONTROLLED TRIAL
1 other identifier
interventional
92
1 country
1
Brief Summary
Inadequate identification of and subsequent delayed therapy for patients with hypoperfusion (including hypovolemia, congestive heart failure and sepsis) is a common problem faced by physicians and intensivists caring for critically ill patients. Bedside clinical assessment is notoriously inaccurate in diagnosing complex etiologies of hemodynamic disturbances and in deciding on the appropriate therapy. Invasive techniques which are often required to guide diagnosis and therapy have significant risks associated with them, are costly, and are time consuming. New technology has been developed that allows for instantaneous, noninvasive monitoring of key hemodynamic parameters, like stroke volume, peak velocity and cardiac output. This new technology has the potential to improve recognition of the etiology of hemodynamic disturbances and assist the clinician in optimizing therapy based on changes in hemodynamic parameters. There is significant potential for this to be translated into improved outcomes in critically ill patients, but this has never been studied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 2, 2011
CompletedFirst Posted
Study publicly available on registry
March 7, 2011
CompletedMarch 7, 2011
March 1, 2011
11 months
March 2, 2011
March 3, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time on vasopressors, measured during the 48 hours after study enrollment
48 hours after study enrollment
Secondary Outcomes (8)
ICU length of stay
At one month (average)
Hospital length of stay
At one month (average)
Duration of mechanical ventilation
At one month (average)
Development of acute renal failure
At one month (average)
Invasive procedures performed after study enrollment
At one month (average)
- +3 more secondary outcomes
Study Arms (2)
Control
NO INTERVENTIONNo measurements are made on the control group.
USCOM
EXPERIMENTALPatients undergo hemodynamic measurements with the ultrasound cardiac output monitor (USCOM). Fluid resuscitation is guided by USCOM measurements.
Interventions
Patients in the intervention group underwent hemodynamic measurements with the ultrasound cardiac output monitor. Based on these measurements, patients were guided through a fluid resuscitation protocol.
Eligibility Criteria
You may qualify if:
- Age 18 yrs or greater
- Administration of vasopressors, defined as a continuous infusion of norepinephrine at a dose \>5 mcg/min, dopamine ≥5 mcg/kg/min or any dose of another vasopressor
- Passage of \<18 hours since initiation of vasopressors at doses specified above
You may not qualify if:
- Hemorrhagic shock
- Need for immediate surgery
- Imminent risk of death in the next 48 hours (as judged by the attending ICU physician)
- Level of care decision that precluded implementation of the study protocol
- Enrollment in any other clinical study
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Barnes-Jewish Hospital
St Louis, Missouri, 63110, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lee M Demertzis, MD
Barnes-Jewish Hospital
- STUDY DIRECTOR
Marin H Kollef, MD
Washington University School of Medicine
- STUDY DIRECTOR
Warren Isakow, MD
Washington University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 2, 2011
First Posted
March 7, 2011
Study Start
January 1, 2010
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
March 7, 2011
Record last verified: 2011-03